Talk Title: Is regional nodal radiotherapy needed in ypN0 patients following neoadjuvant therapy?

VIEWING LOCATION:
Virtual only - TEAMS

Learning Objectives
At the conclusion of this activity, participants should be able to: 

• Review the reported findings of the NSABP B-51 clinical trial
• Evaluate strengths and limitations of currently available evidence for omitting regional nodal radiotherapy after an excellent response to neoadjuvant therapy
•  Summarize clinical application of this emerging data

ATTENDANCE / CREDIT:
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

To claim credit for livestream participation in this course, learners must view the content during the hours posted for the live activity.  This course is not approved for on-demand delivery. 

TRANSCRIPT:
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.

QUESTIONS?
Contact rstgimcme@mayo.edu